DPTX3186, a first-in-class beta-catenin condensate modulator, received Orphan Drug Designation and Fast Track Designation from FDAClinical entry validates condensate modulator…
Initiation of trial marks first-in-human milestone for Neomorph’s novel molecular glue degrader platform February 03, 2026 13:08 ET | Source:…
February 03, 2026 13:06 ET | Source: Restem Initiation of the IIMPACT study follows promising Phase 1 results where Restem-L…
HYDERABAD, India, Jan. 31, 2026 /PRNewswire/ -- International Health Dialogue (IHD) 2026 opened today in Hyderabad, bringing together clinicians, patient…
BANGALORE, India, Jan. 28, 2026 /PRNewswire/ -- Manipal Hospitals, one of India's foremost integrated healthcare providers, has adopted a leading…
SAN DIEGO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company advancing small-molecule inhibition of…
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest, intelligent patient recruitment engine breaking the bottleneck in…
- First patient in the world treated with Alpha DaRT® in the brain – - According to the National Brain…
November 27, 2025 09:30 ET | Source: GS1 Canada TORONTO, Nov. 27, 2025 (GLOBE NEWSWIRE) -- A new report prepared…
HYDERABAD, India, Nov. 24, 2025 /PRNewswire/ -- In an inspiring story of resilience, medical excellence, and a mother's unconditional love,…